Clinical Trials · NCT00979745
Phase III Confirmatory Study in Erythropoietic Protoporphyria (EPP)
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Clinuvel Pharmaceuticals Limited
- Enrollment
- 74
- Start date
- Sep 2009
- Locations
- 8 sites, 6 countries
- Primary endpoint
- The Duration of Direct Sunlight Exposure Between 10:00 and 15:00 Hours on Days When Patients Did Not Report Phototoxicity-related Pain (Likert Pain Scale Score of 0)